newsfilter
← Latest News
PR Newswire·

Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands ...